The decision to temporarily pause the rollout of the AstraZeneca/Oxford COVID-19 vaccine in Denmark due to reports of blood clots has sparked widespread panic. However, as of yet, there is no proven link between the two. In response to the news, Dr Phil Bryan, Medicines and Healthcare products Regulatory Agency (MRHA), Vaccines Safety Lead said: “Vaccine safety is of paramount importance and we continually monitor the safety of vaccines to ensure that the benefits outweigh any potential risks. It has not been confirmed that the report of a blood clot, in Denmark, was caused by the COVID-19 Vaccine AstraZeneca.”
“It has not been confirmed that the report of a blood clot, in Denmark, was caused by the COVID-19 Vaccine AstraZeneca.
“The Danish authorities’ action to temporarily suspend use of the vaccine is precautionary whilst they investigate.
“Blood clots can occur naturally and are not uncommon. More than 11 million doses of the COVID-19 Vaccine AstraZeneca vaccine have now been administered across the UK.
“Reports of blood clots received so far are not greater than the number that would have occurred naturally in the vaccinated population.
READ MORE: AstraZeneca vaccine suspended: Why has Denmark stopped using the Oxford Covid jab?